ArticleFrontiers in pharmacology2020

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer.

Dan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.